کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
5625536 | 1406283 | 2006 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
PerspectivePerspectives on assessing benefits and risks in clinical trials for Alzheimer's disease
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
عصب شناسی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: PerspectivePerspectives on assessing benefits and risks in clinical trials for Alzheimer's disease PerspectivePerspectives on assessing benefits and risks in clinical trials for Alzheimer's disease](/preview/png/5625536.png)
چکیده انگلیسی
Balancing benefits and risks in the development of treatments for Alzheimer's disease is challenging given the nature of the disease but critically important to ensure effective treatments are available. Drawing on a diverse panel of scientists, regulators, caregivers, patients and advocates convened by the Alzheimer's Association, insights are offered into benefit/risk assessment, decision-making, regulatory and societal factors affecting clinical trials on AD. Several policy solutions are offered to improve the drug testing, review and approval process.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Alzheimer's & Dementia - Volume 2, Issue 3, July 2006, Pages 160-163
Journal: Alzheimer's & Dementia - Volume 2, Issue 3, July 2006, Pages 160-163
نویسندگان
Stephen McConnell, Jason Karlawish, Bruno Vellas, Steven DeKosky,